<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>&#13;
&#13;
<head>&#13;
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet"/>&#13;
    <link href="./static/css/outliers.css" rel="stylesheet"/>&#13;
    <meta charset="UTF-8"/>&#13;
</head>&#13;
&#13;
<body>&#13;
    <div class="container"><h1>Static outliers for Lockstown Practice</h1>
<p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
    explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
    prescribers and organisations to audit and review prescribing.</p>
<p>The below reports have been developed to use &#8220;z-scores&#8221; to automatically identify prescribing patterns at a chemical level which are furthest away from &#8220;typical prescribing&#8221; and can be classified as an &#8220;outlier&#8221;. It is important to remember that
    this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
    method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
    We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the &#8220;z-score&#8221;, which is a measure
    of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your &#8220;z-scores&#8221; to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
    for prescribing lower than its peers.</p>
<p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&amp;entry.2016356131=practice+M91021">survey</a>
    or emailing us at
    <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
    feedback.
</p><h2>Prescribing where Lockstown Practice is higher than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0409010AC&amp;denomIds=4.9.1&amp;selectedTab=summary">Apomorphine hydrochloride hemihydrate</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>8</td>&#13;
      <td>Dopaminergic drugs used in parkinsonism</td>&#13;
      <td>213</td>&#13;
      <td>0.04</td>&#13;
      <td>0.0</td>&#13;
      <td>0.0</td>&#13;
      <td>25.17</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0409010ACBBAAAA&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Dacepton 30mg/3ml solution for injection cartridges : 3</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0409010ACBBABAB&amp;denomIds=4.9.1&amp;selectedTab=summary" target="_blank">Dacepton 100mg/20ml solution for infusion vials : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0601012AB&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin glargine/lixisenatide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>12</td>&#13;
      <td>Intermediate and long-acting insulins</td>&#13;
      <td>472</td>&#13;
      <td>0.03</td>&#13;
      <td>0.0</td>&#13;
      <td>0.0</td>&#13;
      <td>17.52</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0601012ABBBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 50microg/ml inj 3ml pf SoloStar pens : 7</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0601012ABBBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 33microg/ml inj 3ml pf SoloStar pens : 5</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0204000U0&amp;denomIds=2.4&amp;selectedTab=summary">Atenolol with calcium channel blocker</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>19</td>&#13;
      <td>Beta-adrenoceptor blocking drugs</td>&#13;
      <td>2381</td>&#13;
      <td>0.01</td>&#13;
      <td>0.0</td>&#13;
      <td>0.0</td>&#13;
      <td>8.38</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0204000U0BCAAAA&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Tenif 50mg/20mg modified-release capsules : 19</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=021200010&amp;denomIds=2.12&amp;selectedTab=summary">Ciprofibrate</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>17</td>&#13;
      <td>Lipid-regulating drugs</td>&#13;
      <td>3874</td>&#13;
      <td>0.00</td>&#13;
      <td>0.0</td>&#13;
      <td>0.0</td>&#13;
      <td>6.12</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=021200010AAAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Ciprofibrate 100mg tablets : 17</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=1304000C0&amp;denomIds=13.4&amp;selectedTab=summary">Beclometasone dipropionate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>3</td>&#13;
      <td>Topical corticosteroids</td>&#13;
      <td>647</td>&#13;
      <td>0.00</td>&#13;
      <td>0.0</td>&#13;
      <td>0.0</td>&#13;
      <td>6.05</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=1304000C0AAAAAA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Beclometasone 0.025% cream : 3</a></div></td></tr></tbody></table>&#13;
&#13;
        <h2>Prescribing where Lockstown Practice is lower than most</h2>&#13;
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">&#13;
  <thead>&#13;
    &#13;
    &#13;
  <tr><th>BNF Chemical</th>&#13;
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>&#13;
      <th>BNF Subparagraph</th>&#13;
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>&#13;
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>&#13;
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>&#13;
      <th><abbr title="Standard Deviation">std</abbr></th>&#13;
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>&#13;
      <th>Plots</th>&#13;
    </tr></thead>&#13;
  &#13;
<tbody><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0902021X0&amp;denomIds=9.2.2&amp;selectedTab=summary">Water for injection</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>1</td>&#13;
      <td>Electrolytes and water</td>&#13;
      <td>13</td>&#13;
      <td>0.08</td>&#13;
      <td>0.82</td>&#13;
      <td>0.26</td>&#13;
      <td>-2.84</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0902021X0AAACAC&amp;denomIds=9.2.2&amp;selectedTab=summary" target="_blank">Water for injections 5ml ampoules : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=1108010B0&amp;denomIds=11.8.1&amp;selectedTab=summary">Carbomer 940/980</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>3</td>&#13;
      <td>Tear deficiency, eye lubricant/astringent</td>&#13;
      <td>219</td>&#13;
      <td>0.01</td>&#13;
      <td>0.34</td>&#13;
      <td>0.15</td>&#13;
      <td>-2.20</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=1108010B0BBABAC&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">Viscotears 2mg/g eye gel 0.6ml unit dose : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=1108010B0BCAAAB&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">GelTears 0.2% gel : 1</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=040201060&amp;denomIds=4.2.1&amp;selectedTab=summary">Olanzapine</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>53</td>&#13;
      <td>Antipsychotic drugs</td>&#13;
      <td>1129</td>&#13;
      <td>0.05</td>&#13;
      <td>0.23</td>&#13;
      <td>0.09</td>&#13;
      <td>-1.97</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=040201060AAACAC&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Olanzapine 10mg tablets : 14</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=040201060AAAQAQ&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Olanzapine 20mg tablets : 3</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=040201060AAADAD&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Olanzapine 2.5mg tablets : 12</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=040201060AAABAB&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Olanzapine 7.5mg tablets : 5</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=040201060AAAAAA&amp;denomIds=4.2.1&amp;selectedTab=summary" target="_blank">Olanzapine 5mg tablets : 19</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0702010G0&amp;denomIds=7.2.1&amp;selectedTab=summary">Estradiol</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>6</td>&#13;
      <td>Preparations for vaginal/vulval changes</td>&#13;
      <td>45</td>&#13;
      <td>0.13</td>&#13;
      <td>0.55</td>&#13;
      <td>0.21</td>&#13;
      <td>-1.94</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0702010G0AAAGAG&amp;denomIds=7.2.1&amp;selectedTab=summary" target="_blank">Estradiol 10microgram pessaries : 2</a><br/><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0702010G0BCABAG&amp;denomIds=7.2.1&amp;selectedTab=summary" target="_blank">Vagifem 10microgram vaginal tablets : 4</a></div></td></tr><tr>&#13;
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91021&amp;numIds=0205020M0&amp;denomIds=2.5.2&amp;selectedTab=summary">Moxonidine</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>&#13;
      <td>0</td>&#13;
      <td>Centrally-acting antihypertensive drugs</td>&#13;
      <td>16</td>&#13;
      <td>0.00</td>&#13;
      <td>0.64</td>&#13;
      <td>0.34</td>&#13;
      <td>-1.92</td>&#13;
      <td><img class="zoom" src="data:image/png;base64,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"/></td>&#13;
    </tr>&#13;
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div/></td></tr></tbody></table>&#13;
&#13;
    </div><script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"/>&#13;
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"/>&#13;
</body>&#13;
&#13;
</html>